Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Czerwinski

Showing results (71-80 of 93) with videos related to

Pageof 10
Sort By:
ACS Chemical Biology|May 13, 2014
ATP-mediated kinome selectivity: the missing link in understanding the contribution of individual JAK Kinase isoforms to cellular signalingAtli Thorarensen, Mary Ellen Banker, Andrew Fensome, et al.
Biochemistry|September 24, 1999
Effects of mutations of the active site arginine residues in 4-oxalocrotonate tautomerase on the pKa values of active site residues and on the pH dependence of catalysisR M Czerwinski, T K Harris, W H Johnson, et al.
Bioorganic Chemistry|June 20, 2006
Inactivation of the phenylpyruvate tautomerase activity of macrophage migration inhibitory factor by 2-oxo-4-phenyl-3-butynoatePavel A Golubkov, William H Johnson, Robert M Czerwinski, et al.
Protein Expression and Purification|March 1, 1996
Purification of a secreted form of recombinant rabies virus glycoprotein: comparison of two affinity tagsB S Wojczyk, M Czerwinski, M M Stwora-Wojczyk, et al.
Bioorganic & Medicinal Chemistry|December 7, 2020
The advantages of describing covalent inhibitor in vitro potencies by IC<sub>50</sub> at a fixed time point. IC<sub>50</sub> determination of covalent inhibitors provides meaningful data to medicinal chemistry for SAR optimizationAtli Thorarensen, Paul Balbo, Mary E Banker, et al.
Biochemistry|October 3, 1999
Enzymatically inactive macrophage migration inhibitory factor inhibits monocyte chemotaxis and random migrationA Hermanowski-Vosatka, S S Mundt, J M Ayala, et al.
Biochemistry|October 3, 2002
The crystal structure of YdcE, a 4-oxalocrotonate tautomerase homologue from Escherichia coli, confirms the structural basis for oligomer diversityJeffrey J Almrud, Andrew D Kern, Susan C Wang, et al.
Biochemistry|August 11, 2004
4-Oxalocrotonate tautomerase, its homologue YwhB, and active vinylpyruvate hydratase: synthesis and evaluation of 2-fluoro substrate analoguesWilliam H Johnson, Susan C Wang, Thanuja M Stanley, et al.
Journal of Animal Science|October 22, 1998
Effects of Synovex-S and recombinant bovine growth hormone (Somavubove) on growth responses of steers: III. Muscle growth and protein responsesT H Elsasser, T S Rumsey, S Kahl, et al.
Journal of the National Cancer Institute|December 6, 1989
Altered regulation of the cytochrome P4501A1 gene: novel inducer-independent gene expression in pulmonary carcinoma cell linesT L McLemore, S Adelberg, M Czerwinski, et al.
Pageof 10

Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
ACS Chemical Biology|May 13, 2014
ATP-mediated kinome selectivity: the missing link in understanding the contribution of individual JAK Kinase isoforms to cellular signalingAtli Thorarensen, Mary Ellen Banker, Andrew Fensome, et al.
Biochemistry|September 24, 1999
Effects of mutations of the active site arginine residues in 4-oxalocrotonate tautomerase on the pKa values of active site residues and on the pH dependence of catalysisR M Czerwinski, T K Harris, W H Johnson, et al.
Bioorganic Chemistry|June 20, 2006
Inactivation of the phenylpyruvate tautomerase activity of macrophage migration inhibitory factor by 2-oxo-4-phenyl-3-butynoatePavel A Golubkov, William H Johnson, Robert M Czerwinski, et al.
Protein Expression and Purification|March 1, 1996
Purification of a secreted form of recombinant rabies virus glycoprotein: comparison of two affinity tagsB S Wojczyk, M Czerwinski, M M Stwora-Wojczyk, et al.
Bioorganic & Medicinal Chemistry|December 7, 2020
The advantages of describing covalent inhibitor in vitro potencies by IC<sub>50</sub> at a fixed time point. IC<sub>50</sub> determination of covalent inhibitors provides meaningful data to medicinal chemistry for SAR optimizationAtli Thorarensen, Paul Balbo, Mary E Banker, et al.
Biochemistry|October 3, 1999
Enzymatically inactive macrophage migration inhibitory factor inhibits monocyte chemotaxis and random migrationA Hermanowski-Vosatka, S S Mundt, J M Ayala, et al.
Biochemistry|October 3, 2002
The crystal structure of YdcE, a 4-oxalocrotonate tautomerase homologue from Escherichia coli, confirms the structural basis for oligomer diversityJeffrey J Almrud, Andrew D Kern, Susan C Wang, et al.
Biochemistry|August 11, 2004
4-Oxalocrotonate tautomerase, its homologue YwhB, and active vinylpyruvate hydratase: synthesis and evaluation of 2-fluoro substrate analoguesWilliam H Johnson, Susan C Wang, Thanuja M Stanley, et al.
Journal of Animal Science|October 22, 1998
Effects of Synovex-S and recombinant bovine growth hormone (Somavubove) on growth responses of steers: III. Muscle growth and protein responsesT H Elsasser, T S Rumsey, S Kahl, et al.
Journal of the National Cancer Institute|December 6, 1989
Altered regulation of the cytochrome P4501A1 gene: novel inducer-independent gene expression in pulmonary carcinoma cell linesT L McLemore, S Adelberg, M Czerwinski, et al.
Pageof 10